EUVIMEDEUVIMED entdecken
Crossref

Immunohistochemical assessment of vimentin expression and Ki-67 proliferation index in conventional urothelial carcinoma: a study of 60 Egyptian patients

Heba M K Youssef, Eman Hassan Ibrahim, Abdulkarim Hasan, Abdulhadi Samman, Mohammed S Abdelwahed, Razan A Baloush, Hussain Noorwali, Deema Abu Al-Teen, Mona Zakaria El Bostany, Amira Nasr, Mahmoud Samir, Essam Mandour und 2 weitere

International Urology and Nephrology · 2026

DOI: 10.1007/s11255-026-05079-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urology and Nephrology, 2026. Verfasst von Heba M K Youssef und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Vimentin, Ki-67 Antigen, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Urothelial carcinoma is a common malignancy with a substantial burden, including in Egypt. Although Ki-67 and EMT-related markers such as vimentin have been previously studied, region-specific validation and practical cutoff performance remain relevant.Author names: Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Also, kindly confirm the details in the metadata are correct. We have made the requested corrections. In addition, we would like to change the author order so that Deema Abu Al-Teen is listed as author number 4, and Abdulhadi Samman is moved to author number 8 in her place, with the same affiliation as currently shown related to each author, Samman (Jeddah) and Abu Al-Teen (Amman). METHODS: This cross-sectional study included 60 archival conventional UC cases diagnosed at university hospitals during 2024. Tumors were re-reviewed to confirm grade and stage and categorized as NMIBC or MIBC. Immunohistochemistry was performed for vimentin and Ki-67 (MIB-1). Vimentin was considered positive when ≥ 10% of tumor cells showed convincing cytoplasmic staining. The Ki-67 labeling index was assessed in hotspots by counting ≥ 500 tumor nuclei and categorized as low (< 30%) versus high (≥ 30%) using a predefined pragmatic cutoff. Multivariable logistic regression was used to identify independent predictors of high-grade disease. RESULTS: Vimentin positivity was detected in 18/60 cases (30.0%), and high Ki-67 index was present in 37/60 (61.7%). High Ki-67 independently predicted high-grade carcinoma (OR = 5.601, p = 0.009) and was significantly associated with high grade (p = 0.011), non-papillary pattern (p < 0.001), and muscle invasion (p = 0.001), but not lymphovascular invasion (p = 0.405). Vimentin showed no significant associations and was not an independent predictor; Ki-67 and vimentin were not significantly correlated. CONCLUSION: In this Egyptian cohort, Ki-67 ≥ 30% was strongly associated with adverse pathological features and independently predicted high-grade disease, supporting its use as a practical ancillary marker and providing regional validation of prior reports. Vimentin was not significantly associated with the studied parameters in this dataset. Future studies should assess alternative cutoffs within the same cohort and validate outcome-linked thresholds in longitudinal datasets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VimentinKi-67 AntigenCarcinoma, Transitional CellUrinary Bladder NeoplasmsHumansFemaleEgyptImmunohistochemistryMiddle AgedCross-Sectional StudiesMaleAgedBiomarkers, TumorCell ProliferationNon-Muscle Invasive Bladder NeoplasmsAdult

Stichwörter der Autor:innen

Bladder cancerImmunohistochemistryKi-67Urothelial carcinomaVimentin

Substanzen

VimentinKi-67 AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates. dr.eman@gmu.ac.ae.
  • Pathology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt. dr.eman@gmu.ac.ae.
  • Pathology Department, Faculty of Medicine, Al-Azhar University, Cairo, 11884, Egypt. abdulkarim.hasan@azhar.edu.eg.
  • Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
  • Department of Basic Dental Sciences, Faculty of Dentistry, Al-Ahliyya Amman University, Amman, Jordan.

Zitieren

APA

Youssef, H. M. K., Ibrahim, E. H., Hasan, A., Samman, A., Abdelwahed, M. S., Baloush, R. A., Noorwali, H., Abu Al-Teen, D., El Bostany, M. Z., Nasr, A., Samir, M., Mandour, E., Rabie, A., & Shokery, S. E. M. (2026). Immunohistochemical assessment of vimentin expression and Ki-67 proliferation index in conventional urothelial carcinoma: a study of 60 Egyptian patients. International Urology and Nephrology. https://doi.org/10.1007/s11255-026-05079-3

Vancouver

Youssef HMK, Ibrahim EH, Hasan A, Samman A, Abdelwahed MS, Baloush RA, et al. Immunohistochemical assessment of vimentin expression and Ki-67 proliferation index in conventional urothelial carcinoma: a study of 60 Egyptian patients. International Urology and Nephrology. 2026. doi:10.1007/s11255-026-05079-3

BibTeX
@article{Youssef2026,
  author = {Youssef, Heba M K and Ibrahim, Eman Hassan and Hasan, Abdulkarim and Samman, Abdulhadi and Abdelwahed, Mohammed S and Baloush, Razan A and Noorwali, Hussain and Abu Al-Teen, Deema and El Bostany, Mona Zakaria and Nasr, Amira and Samir, Mahmoud and Mandour, Essam and Rabie, Ahmed and Shokery, Sara Ehab M},
  title = {Immunohistochemical assessment of vimentin expression and Ki-67 proliferation index in conventional urothelial carcinoma: a study of 60 Egyptian patients},
  journal = {International Urology and Nephrology},
  year = {2026},
  doi = {10.1007/s11255-026-05079-3}
}
Kostenlos starten →